Home › Funds › RA CAPITAL MANAGEMENT, L.P. › JANX
RA CAPITAL MANAGEMENT, L.P. position in JANX
JANUX THERAPEUTICS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 11,189,693 shares of JANX (JANUX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$171.9M, representing 1.49% of its reported portfolio and ranking #17 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed JANX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s JANX position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in JANX in Q3 2023 at 9,165,652 shares (US$92.4M). The position peaked in Q4 2024 at 10,365,652 shares, worth US$555.0M. Across 12 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 11,189,693 shares valued at US$171.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.17M | $92.39M | New |
| Q4 2023 | 9.17M | $98.35M | Hold |
| Q1 2024 | 9.17M | $345.09M | Hold |
| Q2 2024 | 9.17M | $383.95M | Hold |
| Q3 2024 | 9.17M | $416.40M | Hold |
| Q4 2024 | 10.37M | $554.98M | Add |
| Q1 2025 | 11.19M | $302.12M | Add |
| Q2 2025 | 11.19M | $258.48M | Hold |
| Q3 2025 | 11.19M | $273.48M | Hold |
| Q4 2025 | 11.19M | $154.42M | Hold |
| Q1 2026 | 11.19M | $155.54M | Hold |
| Q2 2026 | 11.19M | $171.87M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JANX and 13F data
JANX (JANUX THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in JANX — the largest reported positions include Prosight Management, LP (US$58.4M), TCG Crossover Management, LLC (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JANX
- Prosight Management, LP 3.80M sh · $58.44M · Q2 2026
- TCG Crossover Management, LLC 1.79M sh · $27.49M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held JANX?
RA CAPITAL MANAGEMENT, L.P. has disclosed JANX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in JANX?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 11.19M shares of JANX (JANUX THERAPEUTICS INC), valued at $171.87M, representing 1.49% of its reported portfolio and ranking #17.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling JANX?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in JANX. The position peaked in Q4 2024 at 10.37M shares.
Which other funds hold JANX?
Other major institutional holders of JANX include Prosight Management, LP, TCG Crossover Management, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.